{
"@context": "https://schema.org",
"@type": "Article",
"headline": "Trade Secret Protection & the COVID-19 Cure: Observations on Federal Policy-Making & Potential Impact on Biomedical Advances",
"url": "https://www.lexblog.com/2020/09/14/biomedical-advances/",
"identifier": {
"@type": "PropertyValue",
"name": "LexBlog Library record",
"value": "LEX-WK-1RZJ7983",
"url": "https://www.lexblog.com/lib/1RZJ7983/"
},
"datePublished": "2020-09-14T18:07:54-04:00",
"dateModified": "2020-09-15T06:58:54-04:00",
"author": {
"@type": "Person",
"name": "Steven Hollman, Calla Simeone"
},
"sourceOrganization": {
"@type": "Organization",
"name": "Sheppard, Mullin, Richter & Hampton LLP"
},
"organizationScope": "at-publication",
"isPartOf": "Trade Secrets Law Blog",
"about": "Intellectual Property",
"sourceUrl": "https://www.tradesecretslawblog.com/?p=2073",
"sourceStability": "may-move"
}